Next-Generation Regulatory Synthetic Arms

Eradicating the Physical Placebo

The reliance on physical placebos in terminal neurodegenerative trials—specifically ALS and Lewy Body Dementia—introduces profound bioethical friction and severely bottlenecks patient enrollment. RZST proposes a mathematically rigorous, privacy-preserving substitute: the high-fidelity digital twin. We are architecting computational blueprints designed to replace the physical control group with a causally-validated synthetic baseline, transforming trial equity without sacrificing statistical power.

The FedECA Pipeline Breakthrough

Our proposed multi-agent orchestration layer resolves this by refactoring the sequence of algorithmic operations. Building upon the FedECA methodology validated by Owkin (du Terrail et al., 2025) in Nature Communications, and the decentralized network architecture of D-CLEF (Kuo et al., 2025), we propose deploying Federated External Control Arms by pushing causal inference mathematics strictly behind the simulated hospital firewall.

1. Localized Propensity Scoring: In our simulation, the local node algorithm calculates propensity scores (p_i) and applies the IPTW equations established by du Terrail et al. to mathematically synthesize a balanced, bias-corrected “Pseudo-Population”.
2. Local Training: The isolated neural network (θ_k) is designed to train exclusively on this cleaned reality, generating causal insights rather than biased correlations.
3. Secure Transmission via D-CLEF: Leveraging the decentralized architecture proposed by Kuo et al., the node is designed to securely transmit only the abstract loss gradients and weight updates (ΔW), completely stripped of Protected Health Information.
4. Global Synthesis: The central hub utilizes Federated Averaging to aggregate across all nodes:

   θ_global(t+1) = ∑_k=1^K (n_k / N) · θ_k(t+1)

   • θ_global — Global model (the Virtual Control Arm, T=0)
   • θ_k — Local node model after IPTW-corrected training
   • n_k / N — Weighted contribution of each node
   • K — Total number of federated clinical nodes
   This proposed sequence is designed to synthesize θ_global—a theoretically FDA-compliant Virtual Control Arm derived entirely from decentralized, privacy-preserved data.